Morris, Valerie (2013) AKT Modulates Sensitivity of AML Cells to Gemtuzumab Ozogamicin. Science Spotlight, 3 (3).
Preview |
Text
AKT Modulates Sensitivity of AML Cells to Gemtuzumab Ozogamicin.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (319kB) | Preview |
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | Rosen D.B., Harrington K.H., Cordeiro J.A., Leung L.Y., Putta S., Lacayo N., Laszlo G.S., Gudgeon C.J., Hogge D.E., Hawtin R.E., Cesano A., and Walter R.B. 2013. AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin. PLoS One 8:e53518 Also see: Walter R.B., Appelbaum F.R., Estey E.H., and Bernstein I.D. 2012. Acute myeloid leukemia stem cells and CD33-targeted immunotherapy. Blood 119:6198-208. Irish J.M., Kotecha N., Nolan G.P. 2006. Mapping normal and cancer cell signaling networks: towards single-cell proteomics. Nature Reviews Cancer 6:146-55. |
| Collections: | Science Spotlight |
| Depositing User: | Users 60 not found. |
| Date Deposited: | 19 Mar 2015 21:51 |
| Last Modified: | 19 Mar 2015 21:51 |
| URI: | http://authors.fhcrc.org/id/eprint/830 |
Repository Administrators Only
 |
View Item |
